Cargando…

WHSC1 acts as a prognostic indicator and functions as an oncogene in cervical cancer

Purpose: Wolf–Hirschhorn syndrome candidate 1 (WHSC1) is an epigenetic modifier, considered to play a driving role in oncogenesis. However, very little is known about the roles of WHSC1 and its prognostic impacts in cervical cancer. This study aimed to investigate the role of WHSC1 in the prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jin, Luo, Ming, Duan, Zhaoning, Jia, Ying, Linghu, Hua, Tian, Pu, Qi, Hongbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588087/ https://www.ncbi.nlm.nih.gov/pubmed/31354300 http://dx.doi.org/10.2147/OTT.S204701

Ejemplares similares

GHET1 acts as a prognostic indicator and functions as an oncogenic lncRNA in cervical cancer
por: Zhang, Qunchang, et al.
Publicado: (2019)

Circular RNA WHSC1 exerts oncogenic properties by regulating miR‐7/TAB2 in lung cancer
por: Guan, Sisi, et al.
Publicado: (2021)

In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L
por: Morishita, Masayo, et al.
Publicado: (2014)

The PWWP domain of the human oncogene WHSC1L1/NSD3 induces a metabolic shift toward fermentation
por: Rona, Germana B., et al.
Publicado: (2016)

Additional role of ECC in the detection and treatment of cervical HSIL
por: Sijing, Li, et al.
Publicado: (2023)

Identification of a peptide inhibitor for the histone methyltransferase WHSC1
por: Morrison, Michael J., et al.
Publicado: (2018)

WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer
por: Saloura, Vassiliki, et al.
Publicado: (2017)

WHSC1/NSD2 regulates immune infiltration in prostate cancer
por: Want, Muzamil Y, et al.
Publicado: (2021)

Inhibition of WHSC1 Allows for Reprogramming of the Immune Compartment in Prostate Cancer
por: Want, Muzamil Y., et al.
Publicado: (2021)

WHSC1 is involved in DNA damage, cellular senescence and immune response in hepatocellular carcinoma progression
por: Yan, Jia, et al.
Publicado: (2023)

Imbalance of Vaginal Microbiota and Immunity: Two Main Accomplices of Cervical Cancer in Chinese Women
por: Li, Xiaoge, et al.
Publicado: (2023)

SYDE1 Acts as an Oncogene in Glioma and has Diagnostic and Prognostic Values
por: Han, Zhenyuan, et al.
Publicado: (2021)

MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents
por: Shah, Mrinal Y., et al.
Publicado: (2016)

The NSD2/WHSC1/MMSET methyltransferase prevents cellular senescence‐associated epigenomic remodeling
por: Tanaka, Hiroshi, et al.
Publicado: (2020)

Linc01105 acts as an oncogene in the development of neuroblastoma
por: Ye, Mujie, et al.
Publicado: (2021)

The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation
por: Kojima, Machiko, et al.
Publicado: (2019)

Wolf–Hirschhorn Syndrome Candidate 1 (whsc1) Functions as a Tumor Suppressor by Governing Cell Differentiation
por: Yu, Chuan, et al.
Publicado: (2017)

WHSC1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Activating mTORC1 Signaling
por: Dai, Jingjing, et al.
Publicado: (2020)

Extracellular vesicle-derived CircWhsc1 promotes cardiomyocyte proliferation and heart repair by activating TRIM59/STAT3/Cyclin B2 pathway
por: Wei, Guoquan, et al.
Publicado: (2022)

Association of Cervical Dysbacteriosis, HPV Oncogene Expression, and Cervical Lesion Progression
por: Liu, Hang, et al.
Publicado: (2022)

De novo loss-of-function variants in NSD2 (WHSC1) associate with a subset of Wolf–Hirschhorn syndrome
por: Barrie, Elizabeth S., et al.
Publicado: (2019)

CircRNA WHSC1 targets the miR‐646/NPM1 pathway to promote the development of endometrial cancer
por: Liu, Yao, et al.
Publicado: (2020)

Histone methyltransferase WHSC1 inhibits colorectal cancer cell apoptosis via targeting anti-apoptotic BCL2
por: Wang, Yu, et al.
Publicado: (2021)

Identifying genes as potential prognostic indicators in patients with serous ovarian cancer resistant to carboplatin using integrated bioinformatics analysis
por: Zhan, Shi-Jie, et al.
Publicado: (2018)

Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ–stimulated antitumor immunity
por: Ren, Jiale, et al.
Publicado: (2022)

The Histone Methyltransferase MMSET/WHSC1 Activates TWIST1 to Promote an Epithelial-Mesenchymal Transition and Invasive Properties of Prostate Cancer
por: Ezponda, Teresa, et al.
Publicado: (2012)

WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2020)

Correction to: Histone methyltransferase WHSC1 inhibits colorectal cancer cell apoptosis via targeting anti-apoptotic BCL2
por: Wang, Yu, et al.
Publicado: (2021)

Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma
por: Zhu, Xin, et al.
Publicado: (2014)

CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular Carcinoma()
por: Yang, Yu-Feng, et al.
Publicado: (2018)

Correction: Pim-1 acts as an oncogene in human salivary gland adenoid cystic carcinoma
por: Zhu, Xin, et al.
Publicado: (2022)

Prognostic Values of Platelet-Associated Indicators in Resectable Cervical Cancer
por: Wang, Jing-mei, et al.
Publicado: (2019)

Histone H3 Lysine 36 Methyltransferase Whsc1 Promotes the Association of Runx2 and p300 in the Activation of Bone-Related Genes
por: Lee, Yu Fei, et al.
Publicado: (2014)

CNN3 acts as a potential oncogene in cervical cancer by affecting RPLP1 mRNA expression
por: Xia, Lili, et al.
Publicado: (2020)

ADAR1 has an oncogenic function and can be a prognostic factor in cervical cancer
por: Nakamura, Keiichiro, et al.
Publicado: (2023)

Long noncoding RNA KCNMB2-AS1 acts as an oncogene in ovarian cancer: KCNMB2-AS1 acts as an oncogene in ovarian cancer
por: Cao, Siyu, et al.
Publicado: (2023)

Pinin acts as a poor prognostic indicator for renal cell carcinoma by reducing apoptosis and promoting cell migration and invasion
por: Jin, Ming, et al.
Publicado: (2021)

LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer
por: Song, Yang, et al.
Publicado: (2021)

MicroRNA-23a acts as an oncogene in pancreatic carcinoma by targeting TFPI-2
por: Wang, Wei, et al.
Publicado: (2020)

LncRNA-RMRP Acts as an Oncogene in Lung Cancer
por: Meng, Qingjun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jr1hq95udgspdcs6pp3k8m0b7t